McEvoy & Farmer Pathology provides both custom and syndicated research on the business of cancer testing. If you are curious about instrumentation employed, test volumes in any country, costs of laboratory services, or the future of these technologies we can probably answer your questions quickly and affordably.
- Next generation sequencing
- PCR or ISH- based companion diagnostics
- Core histology – tissue processing, primary staining, sectioning, embedding, sample identification
- Pap and HPV screening for cervical cancer
- Whole slide imaging
- Flow cytometry
- Serum tumor markers
- Circulating tumor cells/liquid biopsies
We are midway through a three-year project to assess the cancer testing activity in world’s ten biggest countries.
In December 2011 we published our China report. Click here for excerpts
In December 2014 we published our Japan report. Click here for excerpts
In June 2014 we published our Brazil report. Click here for excerpts
In January 2015 we published the fifth edition our US report. Click here for excerpts
We expect the reports on Germany and France to be published in June 2015. Italy and Spain will follow near the end of 2015.
As a result of our investment in the syndicated studies, we can be very efficient at custom market research in any of these places.